Nirmal Kaur

Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease

Monika Fischer, Dina Kao, Colleen Kelly et al. · Inflammatory Bowel Diseases · 2016 · 180 citations · Full text

Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience

Yao‐Wen Cheng, Emmalee Phelps, Vincent Ganapini et al. · American Journal of Transplantation · 2018 · 135 citations · Full text

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 89 citations · Full text

Inflammation, Anti-inflammatory, Immunology +7

Liver Injury Secondary to Anti-TNF-Alpha Therapy in Inflammatory Bowel Disease: A Case Series and Review of the Literature

Ravish Parekh, Nirmal Kaur · Case Reports in Gastrointestinal Medicine · 2014 · 31 citations · Full text

Tnf- α, Liver Fibrosis, Immunology +21

Diabetic retinopathy among type 2 diabetes mellitus patients in Sabah primary health clinics–Addressing the underlying factors

Nurul Athirah Naserrudin, Mohammad Saffree Jeffree, Nirmal Kaur et al. · PLoS ONE · 2022 · 23 citations · Full text

Diabetic Retinopathy, Hypertension, Diabetes Epidemiology +14